Janssen Search
Search results
Johan Verbeeck, DVM
JOHAN VERBEECK, DVM VICE PRESIDENT JANSSEN BUSINESS DEVELOPMENT ONCOLOGY Johan Verbeeck, DVM is Vice President, Janssen Business Development, Oncology where he leads business development planning in support of the Oncology Therapeutic Area. His ...
Iqbal Grewal, Ph.D., D.Sc., F.R.C.Path
Iqbal Grewal, Ph.D., D.Sc., F.R.C.Path is Vice President, Head of Immuno-Oncology in the Oncology Therapeutic Area at Janssen Research & Development, LLC. He leads research efforts at Janssen to discover and develop therapeutics that function as ...
Scott White
SCOTT WHITE Company Group Chairman North America Pharmaceuticals Johnson & Johnson Scott White is Company Group Chairman, North America, at the Janssen Pharmaceutical Companies of Johnson & Johnson. A member of the Pharmaceuticals Group Operating ...
Cancer Interception and the Tumor Microenvironment
Cancer Interception and the Tumor Microenvironment “We are intent on understanding what turns healthy cells into cancerous cells and continue to make progress in this area. These critical insights will help us advance medicines to interrupt the process ...
Pulmonary Hypertension Overview
Pulmonary Hypertension At Janssen, we are spearheading a new era for pulmonary hypertension (PH), working to transform the disease into a long-term manageable condition, so that patients can live a normal life. Building on Actelion's 20-year ...
ASH 2020 Newsroom
The American Society of Hematology (ASH) has moved to a virtual platform for the 2020 Annual Meeting, and Janssen Oncology will have a strong showing at ASH with more than 35 company-sponsored presentations highlighting our deep, diverse oncology pipeline ...
John C. Reed, M.D., Ph.D.
JOHN C. REED, M.D., PH.D. EXECUTIVE VICE PRESIDENT PHARMACEUTICALS, R&D JOHNSON & JOHNSON As Executive Vice President, Pharmaceuticals, R&D and Johnson & Johnson (J&J) Executive Committee member, John’s mission is to focus the best ...
Disease Interception Accelerator
Thinking Differently About Healthcare Article Type: World Without Disease Accelerator Research & Development We envision a future where the term “patient” becomes a thing of the past, because intervening and stopping disease from progressing in ...
Data Sciences Overview
The Vision for Data Science at Janssen R&D Data Science and Digital Health are among the most exciting revolutions of our time, transforming how we discover, develop and deliver new therapies and vaccines to advance our ultimate mission of bringing ...
Janssen Signs with Yale Open Data Access
Janssen Signs First-of-its-Kind Agreement With Yale School of Medicine’s Open Data Access Project Janssen Research & Development (R&D) signed a first-of-its-kind agreement with Yale School of Medicine’s Open Data Access (YODA) Project to ...